Geriatric Recovery Using Inpatient and Post-hospitalization Supplementation
NCT ID: NCT03904615
Last Updated: 2024-12-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
116 participants
INTERVENTIONAL
2019-06-19
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Whey Protein
30 g of whey protein twice daily during hospitalization and for 30 days after discharge
Whey Protein
30 g of whey protein in flavored water, twice daily, during hospitalization and for 30 days post-discharge
Collagen Protein
30 g of collagen protein twice daily during hospitalization and for 30 days after discharge
Collagen Protein
30 g of collagen protein in flavored water, twice daily, during hospitalization and for 30 days post-discharge
Placebo
30 g of maltodextrin twice daily during hospitalization and for 30 days after discharge
Placebo
30 g of maltodextrin in flavored water, twice daily, during hospitalization and for 30 days post-discharge
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whey Protein
30 g of whey protein in flavored water, twice daily, during hospitalization and for 30 days post-discharge
Collagen Protein
30 g of collagen protein in flavored water, twice daily, during hospitalization and for 30 days post-discharge
Placebo
30 g of maltodextrin in flavored water, twice daily, during hospitalization and for 30 days post-discharge
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to UTMB hospital for any acute medical condition
* English speaking
Exclusion Criteria
* Bed or wheelchair bound prior to hospitalization
* Estimated creatinine clearance 20 ml/min or less, or end stage renal disease not on dialysis
* AST/ALT 2.5 times above the normal limit
* Active cancer
* Palliative care/Hospice
* Estimated protein intake \>1.2 g/kg/day during the previous 24 hours
* Any other condition or event considered exclusionary by the PI and faculty physician
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dairy Management Inc.
INDUSTRY
The University of Texas Medical Branch, Galveston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elena Volpi, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
UTMB
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UTMB Acute Care for Elders Unit
Galveston, Texas, United States
Jennie Sealy Hospital
Galveston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-0247
Identifier Type: -
Identifier Source: org_study_id